Metolazone IV (Hyloris pharmaceuticals)

N/A

Report date: 2025/03/11 15:28:12

Base Information

Drug NameMetolazone IV (Hyloris pharmaceuticals)
Drug Alias NameHY-032 Metolazone IVHY-CVS-032
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporter
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHyloris Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesHyloris Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A